|
Based on the available information, this event is deemed to be a reportable malfunction.Batch record review: lot: 3g03477 was manufactured 19/jul/2023, in doyen a line, with a total of (b)(4) market units (mkus).The complaints investigator performed a batch record review on 11/aug/2025, to verify if all the applicable procedures were followed and no issues were found; all the components for assembly were correct per bill of materials (bom) and all the tooling information documented was also correct, system application product (sap) material identification (id): 1704767 and manufacturing order: (b)(4).Review of the batch record showed that all relevant tests required during the manufacturing process and final product release had been fulfilled and met the requirements.No discrepancy related to this issue was found within the documentation.The defect reported by the customer could occur during the sub-assembly process performed in the extrusion, lamination & cutting process (elc) #10 manufacturing line.For this reason, a detailed batch record review was performed of the subassembly lot manufactured in this line.The subassembly lot: 3g00374, order: (b)(4), material: 1003168, was manufactured on 13/jul/2023 in the extrusion, lamination & cutting process (elc) #10 manufacturing line, with a total of (b)(4) each.The complaint investigator performed a batch record review on 11/aug/2025 and it was confirmed that the applicable procedures were followed, the components for assembly were correct as per bill of materials (bom) and the equipment settings were the applicable ones.The batch record review supports that there were no discrepancies related to the issue reported.The subassembly lot: 3e04532, order: (b)(4), material: 1003168, was manufactured on 31/may/2023 in the extrusion, lamination & cutting process (elc) #10 manufacturing line, with a total of (b)(4) each.The complaint investigator performed a batch record review on 11/aug/2025 and it was confirmed that the applicable procedures were followed, the components for assembly were correct as per bill of materials (bom) and the equipment settings were the applicable ones.The batch record review supports that there were no discrepancies related to the issue reported.Photograph, video and/or physical sample evaluation: no photographs associated with this case were received and no unused return sample was expected.Historical complaints review: on 11/aug/2025, complaints investigator ran a query in database in order to verify the complaints reported for the 3g03477 lot for the malfunction ¿adhesive dressing requires excessive force for removal from skin (i.E.Difficult to remove)¿ defect and no additional complaints were identified.Historical nonconformance review: on 11/aug/2025, complaints investigator ran a query in database looking for any in process nonconformance / corrective and preventive actions (capa) (s) associated to the malfunction ¿adhesive dressing requires excessive force for removal from skin (i.E.Difficult to remove)¿ defect for the lot number: 3g03477 and as result, no nonconformance / corrective and preventive actions (capa) (s) for this malfunction were generated during the manufacturing process of the referenced lot.Current quality controls: based on the process instruction (pi), the following tests are performed in the manufacturing lines, in order to identify this failure mode in our manufacturing process: test methods (tm) "rolling ball tack test": frequency: first unit, sample quantity: 2 samples, acceptance criteria: nmt 1" travel.Defect rate analysis: there have only been 1 defective part confirmed to date from a lot size of (b)(4) products.This represents a defect rate of only (b)(4), which is well within an appropriate acceptable quality level (aql) for this defect which should be 0.65% based on our standard operating procedure (sop).In addition, all of the in-process testing on this lot did not find a single defective unit, which confirms that the lot is unlikely to breach an acceptable quality level (aql) of 0.65.To date, it is well within our accepted acceptable quality level (aql) level for this type of failure mode or defect.Conclusion: no photographs for this complaint issue.Therefore, it was not possible to conduct an investigation for the reported issue.A review of batch records was completed and showed that all relevant tests required during the manufacturing process and final product release had been fulfilled and met the requirements.No discrepancies related to this issue were found within the documentation.This issue will be monitored through the post market product monitoring review process, standard operating procedure (sop).To date no additional information has been received.Should additional information become available, a follow-up report will be submitted.Fda registration number: reporting site: 1049092, manufacturing site: 9618003.
|